{
    "id": "4e63b36e-3d75-b3b0-42b6-f2f3c1ddf4d0",
    "indications": {
        "text": "everolimus tablets kinase inhibitor indicated treatment : postmenopausal women advanced hormone receptor-positive , her2-negative breast cancer combination exemestane failure treatment letrozole anastrozole . ( 1.1 ) adults renal angiomyolipoma tuberous sclerosis complex ( tsc ) , requiring immediate surgery . ( 1.4 ) everolimus tablets kinase inhibitors indicated treatment adult pediatric patients aged 1 year older tsc subependymal giant cell astrocytoma ( sega ) requires therapeutic intervention curatively resected . ( 1.5 )",
        "doid_entities": [
            {
                "text": "breast cancer (DOID:1612)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1612"
            },
            {
                "text": "cancer (DOID:162)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_162"
            },
            {
                "text": "renal angiomyolipoma (DOID:8411)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_8411"
            },
            {
                "text": "angiomyolipoma (DOID:3314)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_3314"
            },
            {
                "text": "tuberous sclerosis (DOID:13515)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_13515"
            },
            {
                "text": "subependymal giant cell astrocytoma (DOID:5077)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_5077"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "combine everolimus tablets afinitor disperz achieve total daily dose . ( 2.1 ) modify dose patients hepatic impairment patients taking drugs inhibit induce p-glycoprotein ( p-gp ) cyp3a4 . ( 2.1 ) breast cancer : 10 mg orally daily . ( 2.2 ) tsc-associated renal angiomyolipoma : 10 mg orally daily . ( 2.5 ) tsc-associated sega : 4.5 mg/m 2 orally daily ; adjust dose attain trough concentrations 5-15 ng/ml . ( 2.6 , 2.8 )",
        "doid_entities": [
            {
                "text": "breast cancer (DOID:1612)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1612"
            },
            {
                "text": "cancer (DOID:162)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_162"
            },
            {
                "text": "renal angiomyolipoma (DOID:8411)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_8411"
            },
            {
                "text": "angiomyolipoma (DOID:3314)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_3314"
            },
            {
                "text": "sega (DOID:5077)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_5077"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "everolimus tablets 2.5 mg tablets : white white , capsule shaped , flat faced bevelled edge tablet debossed b 2.5 one side plain side ; available : bottle 30 tablets child resistant closure - ndc 70377-010-11 blisters 28 tablets - ndc 70377-010-22 blisters 28 tablets ( desiccant embedded alu-alu blister pack ) -ndc 70377-010-23 carton contains 4 blister cards 7 tablets 5 mg tablets : white white , capsule shaped , flat faced bevelled edge tablet debossed b 5 one side plain side ; available : bottle 30 tablets child resistant closure - ndc 70377-011-11 blisters 28 tablets - ndc 70377-011-22 blisters 28 tablets ( desiccant embedded alu-alu blister pack ) - ndc 70377-011-23 carton contains 4 blister cards 7 tablets 7.5 mg tablets : white white , capsule shaped , flat faced bevelled edge tablet debossed b 7.5 one side plain side ; available : bottle 30 tablets child resistant closure - ndc 70377-012-11 blisters 28 tablets - ndc 70377-012-22 blisters 28 tablets ( desiccant embedded alu-alu blister pack ) - ndc 70377-012-23 carton contains 4 blister cards 7 tablets 10 mg tablets : white white , capsule shaped , flat faced bevelled edge tablet debossed b 10 one side plain side ; available : bottle 30 tablets child resistant closure - ndc 70377-013-11 blisters 28 tablets - ndc 70377-013-22 blisters 28 tablets ( desiccant embedded alu-alu blister pack ) - ndc 70377-013-23 carton contains 4 blister cards 7 tablets store 25\u00b0c ( 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) . usp controlled room temperature . store original container , protect light moisture . follow special handling disposal procedures anticancer pharmaceuticals.1",
    "adverseReactions": "everolimus tablets contraindicated patients clinically significant hypersensitivity everolimus rapamycin derivatives [ ( 5.3 ) ] .",
    "ingredients": [
        {
            "name": "ANHYDROUS LACTOSE",
            "code": "3SY5LH9PMK",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "BUTYLATED HYDROXYTOLUENE",
            "code": "1P9D0Z171K",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_24751"
        },
        {
            "name": "CROSPOVIDONE",
            "code": "2S7830E561"
        },
        {
            "name": "HYPROMELLOSE 2208 (3 MPA.S)",
            "code": "9H4L916OBU",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "Everolimus",
            "code": "9HW64Q8G6G",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_68478"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        }
    ],
    "organization": "Biocon Pharma Inc.",
    "name": "EVEROLIMUS",
    "effectiveTime": "20250321",
    "indications_original": "Everolimus tablets are kinase inhibitor indicated for the treatment of: Postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer in combination with exemestane after failure of treatment with letrozole or anastrozole. ( 1.1 ) Adults with renal angiomyolipoma and tuberous sclerosis complex (TSC), not requiring immediate surgery. ( 1.4 ) Everolimus tablets are kinase inhibitors indicated for the treatment of adult and pediatric patients aged 1 year and older with TSC who have subependymal giant cell astrocytoma (SEGA) that requires therapeutic intervention but cannot be curatively resected. ( 1.5 )",
    "contraindications_original": "Do not combine everolimus tablets and AFINITOR DISPERZ to achieve the total daily dose. ( 2.1 ) Modify the dose for patients with hepatic impairment or for patients taking drugs that inhibit or induce P-glycoprotein (P-gp) and CYP3A4. ( 2.1 ) Breast Cancer: 10 mg orally once daily. ( 2.2 ) TSC-Associated Renal Angiomyolipoma: 10 mg orally once daily. ( 2.5 ) TSC-Associated SEGA: 4.5 mg/m 2 orally once daily; adjust dose to attain trough concentrations of 5-15 ng/mL. ( 2.6 , 2.8 )",
    "warningsAndPrecautions_original": "Everolimus tablets\n                  2.5 mg tablets: White to off white, capsule shaped, flat faced bevelled edge tablet debossed with B 2.5 on one side and plain on other side; available in:\n                  \n                  Bottle of 30 tablets with child resistant closure ------------------------ NDC 70377-010-11\n                  Blisters of 28 tablets ------------------------------------------------------- NDC 70377-010-22\n                  Blisters of 28 tablets (Desiccant Embedded Alu-Alu Blister pack) --NDC 70377-010-23\n                  Each carton contains 4 blister cards of 7 tablets each\n                  \n                  5 mg tablets: White to off white, capsule shaped, flat faced bevelled edge tablet debossed with B 5 on one side and plain on other side; available in:\n                  \n                  Bottle of 30 tablets with child resistant closure ------------------------ NDC 70377-011-11\n                  Blisters of 28 tablets ------------------------------------------------------- NDC 70377-011-22\n                  Blisters of 28 tablets (Desiccant Embedded Alu-Alu Blister pack)-- NDC 70377-011-23\n                  Each carton contains 4 blister cards of 7 tablets each\n                  \n                  7.5 mg tablets: White to off white, capsule shaped, flat faced bevelled edge tablet debossed with B 7.5 on one side and plain on other side; available in:\n                  \n                  Bottle of 30 tablets with child resistant closure ------------------------ NDC 70377-012-11\n                  Blisters of 28 tablets ------------------------------------------------------- NDC 70377-012-22\n                  Blisters of 28 tablets (Desiccant Embedded Alu-Alu Blister pack)-- NDC 70377-012-23\n                  Each carton contains 4 blister cards of 7 tablets each\n                  \n                  10 mg tablets: White to off white, capsule shaped, flat faced bevelled edge tablet debossed with B 10 on one side and plain on other side; available in:\n                  \n                  Bottle of 30 tablets with child resistant closure ------------------------ NDC 70377-013-11\n                  Blisters of 28 tablets ------------------------------------------------------- NDC 70377-013-22\n                  Blisters of 28 tablets (Desiccant Embedded Alu-Alu Blister pack)-- NDC 70377-013-23\n                  Each carton contains 4 blister cards of 7 tablets each\n                  \n                  Store at 25\u00b0C (77\u00b0F); excursions permitted between 15\u00b0C to 30\u00b0C (59\u00b0F to 86\u00b0F). See USP Controlled Room Temperature.\n                  \n                  Store in the original container, protect from light and moisture.\n                  Follow special handling and disposal procedures for anticancer pharmaceuticals.1",
    "adverseReactions_original": "Everolimus tablets are contraindicated in patients with clinically significant hypersensitivity to everolimus or to other rapamycin derivatives [see Warnings and Precautions (5.3)].",
    "drug": [
        {
            "name": "EVEROLIMUS",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_68478"
        }
    ]
}